The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2018The Role of FcgRIIb in Alpha-synuclein Toxicity and Spread
Study Rationale:
People with Parkinson's disease (PD) have clumps of protein alpha-synuclein in the brain. As PD progresses, these clumps spread through the brain, damaging nerve cells (neurons) that... -
Research Grant, 2018Assessing the Effects of Parkin Activation in Pre-clinical Models
Study Rationale:
Protein parkin is involved in several subtypes of Parkinson's disease (PD). Loss of its activity leads to early-onset Parkinson's; therefore, increasing parkin activity may improve... -
Research Grant, 2018The Role of LRRK2 in Immune Response and Neurodegeneration Caused by Mitochondrial Dysfunction
Study Rationale:
Although mutations (changes) in the LRRK2 gene are more common than changes in other disease-linked genes in people with Parkinson's disease (PD), it remains unclear how the LRRK2 mut... -
Alpha-Synuclein Biology and Therapies, 2018Studying the Function of Modified Alpha-synuclein in Health and Disease
Study Rationale:
The exact cause of brain cell death in people with Parkinson's disease (PD) is not fully understood. Studies have revealed clumps of protein alpha-synuclein in brain cells. Modified... -
Research Grant, 2018Gait as a Measure of Parkinson's Disease
Study Rationale:
Gait impairment -- difficulty walking -- is arguably among the most disabling symptoms of Parkinson's disease (PD), as safe walking is critical for maintaining independence and... -
Research Grant, 2018Tracing Hallmarks of Parkinson's Disease in the Brain with a New Compound
Study Rationale:
Parkinson's disease (PD) is characterized by the presence of protein alpha-synuclein clumps in the brain. PD shares common features with other neurodegenerative diseases and because an...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.